Department of Infectious Diseases, Hospital Centre of São João (Centro Hospitalar de São João), Porto, Portugal.
Department of Infectious Diseases, Hospital Centre of São João (Centro Hospitalar de São João), Porto, Portugal; Infection and Antimicrobial Resistance Control and Prevention Unit, Hospital Epidemiology Centre, Centro Hospitalar de São João, Porto, Portugal.
Int J Antimicrob Agents. 2018 Jun;51(6):925-931. doi: 10.1016/j.ijantimicag.2018.01.005. Epub 2018 Jan 12.
A prospective audit and feedback antimicrobial stewardship intervention conducted in the Orthopaedics Department of a university hospital in Portugal was evaluated by comparing an interrupted time series in the intervention group with a non-intervention (control) group. Monthly antibiotic use (except cefazolin) was measured as the World Health Organization's Anatomical Therapeutic Chemical defined daily doses (ATC-DDD) from January 2012 to September 2016, excluding the 6-month phase of intervention implementation starting on 1 January 2015. Compared with the control group, the intervention group had a monthly decrease in the use of fluoroquinolones by 2.3 DDD/1000 patient-days [95% confidence interval (CI) -3.97 to -0.63]. An increase in the use of penicillins by 103.3 DDD/1000 patient-days (95% CI 47.42 to 159.10) was associated with intervention implementation, followed by a decrease during the intervention period (slope = -5.2, 95% CI -8.56 to -1.82). In the challenging scenario of treatment of osteoarticular and prosthetic joint infections, an audit and feedback intervention reduced antibiotic exposure and spectrum.
一项在葡萄牙一所大学医院骨科进行的前瞻性审核和反馈抗菌药物管理干预研究,通过比较干预组和非干预组(对照组)的中断时间序列进行了评估。每月抗生素使用量(头孢唑林除外)以世界卫生组织的解剖治疗化学定义日剂量(ATC-DDD)进行测量,时间范围为 2012 年 1 月至 2016 年 9 月,不包括 2015 年 1 月 1 日开始的为期 6 个月的干预实施阶段。与对照组相比,干预组每月氟喹诺酮类药物的使用量减少了 2.3 DDD/1000 患者日(95%置信区间为-3.97 至-0.63)。干预实施后,青霉素类药物的使用量增加了 103.3 DDD/1000 患者日(95%置信区间为 47.42 至 159.10),随后在干预期间减少(斜率=-5.2,95%置信区间为-8.56 至-1.82)。在治疗骨关节炎和人工关节感染的挑战性情况下,审核和反馈干预措施减少了抗生素的暴露和种类。